Skip to main content
. 2022 Nov 25;12(23):4181. doi: 10.3390/nano12234181

Figure 3.

Figure 3

(a) Effect of [177Lu]Lu−iFAP/iPSMA treatment on HCT116 colorectal cancer xenograft tumors in nu/nu mice. Note a significant decrease in the relative tumor volume in mice treated with the nanoparticles compared to the control group. (b) Representative light micrographs (magnification of 400×) of immunohistochemical staining (dark brown color) for cell proliferation markers Ki67 and pEGFR in colorectal cancer xenograft tumors. Note the significant effect of [177Lu]Lu−iFAP/iPSMA on the decrease of tumor cell proliferation with regard to the control group. * Statistically significant difference (p < 0.05).